Tilray (TLRY) began trading on the Nasdaq on 19 July 2018

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa.

• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic
• Full Time Employees: 313
• Headquarters: Nanaimo, BC, Canada
• Founded: 2013
• http://www.tilray.com